US FDA’s MIDD Program Could Expand Beyond Quarterly Requests, But Needs Resources

 
• By Derrick Gingery
  
clinical trials
MIDD requests could be submitted more often, but resources are an issue. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D